Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S2213-8587(21)00242-4
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858721002424
其他信息:
出版社: Elsevier BV
作者: Hiddo J L Heerspink; Niels Jongs; Glenn M Chertow; Anna Maria Langkilde; John J V McMurray; Ricardo Correa-Rotter; Peter Rossing; C David Sjöström; Bergur V Stefansson; Robert D Toto; David C Wheeler; Tom Greene

